title: Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
authors.forename: Zukile
authors.initials: Z
authors.lastname: Gqada
authors.forename: Ben
authors.initials: B
authors.lastname: Marais
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Wasserman
authors.forename: Colleen
authors.initials: C
authors.lastname: Bamford
authors.forename: Heidi
authors.initials: H
authors.lastname: Orth
authors.forename: George
authors.initials: G
authors.lastname: Sakoulas
authors.forename: Warren
authors.initials: W
authors.lastname: Rose
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Rybak
authors.forename: Satish
authors.initials: S
authors.lastname: Pillai
authors.forename: Jeff
authors.initials: J
authors.lastname: Alder
authors.forename: Robert C
authors.initials: RC
authors.lastname: Moellering
authors.forename: George M
authors.initials: GM
authors.lastname: Eliopoulos
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017576:Daptomycin / Q000494:pharmacology / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin